RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021
September 01 2021 - 7:00AM
RxSight, Inc., (NASDAQ: RXST) an ophthalmic medical device company,
today announced an updated date for reporting second quarter 2021
financial results. In observance of the Rosh Hashanah holiday, the
company will now report after the market close on Thursday,
September 9, 2021. Management will discuss the results during a
conference call beginning that day at 1:30 p.m. Pacific Time / 4:30
p.m. Eastern Time.
Investors interested in listening to the conference call may do
so by accessing a live and archived webcast of the event at
https://investors.rxsight.com/.
About RxSight, Inc.RxSight, Inc. is a
commercial-stage medical technology company dedicated to improving
the vision of patients following cataract surgery. The RxSight®
Light Adjustable Lens system, comprised of the RxSight Light
Adjustable Lens (LAL®), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that enables doctors to customize
and optimize visual acuity for patients after cataract surgery. The
LAL now features ActivShield™ technology, a revolutionary UV
protection layer built into the lens. Additional information about
RxSight can be found at www.rxsight.com.
Investor Relations Contact:Philip Taylor
Gilmartin Group415.937.5406IR@rxsight.com
Company contact:Roy FreemanSr. Director,
Marketingrfreeman@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jun 2024 to Jul 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Jul 2023 to Jul 2024